covid
Buscar en
Angiología
Toda la web
Inicio Angiología Proteína C reactiva como factor pronóstico de mortalidad en los aneurismas de ...
Información de la revista
Vol. 57. Núm. 3.
Páginas 225-236 (enero 2004)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 57. Núm. 3.
Páginas 225-236 (enero 2004)
Acceso a texto completo
Proteína C reactiva como factor pronóstico de mortalidad en los aneurismas de aorta abdominal rotos
C-Reactive protein as a prognostic factor for mortality in ruptured abdominal aortic aneurysms
Visitas
4057
J.C. Bohórquez-Sierraa,
Autor para correspondencia
jcbsierra@terra.es

Unidad de Angiología y Cirugía Vascular. Hospital Universitario Puerta del Mar. Avda.Ana de Viya, 21. E-11009 Cádiz. Fax: +34 95600 2491.
, E. Doiz-Artázcoza, E. Ocañab, A. Craven-Bartlea, M. Rodríguez-Piñeroa, C. Bohórquez-Sierraa
a Unidad de Angiología y Cirugía Vascular.
b Servicio de Inmunología. Hospital Universitario Puerta del Mar. Cádiz, España.
Este artículo ha recibido
Información del artículo
Resumen

Objetivo. Determinar si el valor plasmático preoperatorio de diversos marcadores biológicos de inflamación –proteína C reactiva (PCR), leucocitos y fibrinógeno– se asocia a la mortalidad de los pacientes con rotura de aneurisma de aorta abdominal (AAA). Pacientes y métodos. Estudio prospectivo de 37 pacientes intervenidos quirúrgicamente de AAA roto. Se extrajo una muestra de sangre periférica a cada uno de ellos para el estudio preoperatorio de los biomarcadores de inflamación. Además, se recogieron datos correspondientes a variables clínicas pre, intra y postoperatorias. Para el análisis de los valores plasmáticos de PCR se utilizó un test convencional (Tina-Quant). Resultados. De los marcadores biológicos de inflamación estudiados, sólo la PCR fue un factor pronóstico de mortalidad perioperatoria, y la mediana fue significativamente superior en los fallecidos en comparación con los supervivientes (p=0,021). Se categorizó la PCR en dos grupos con la utilización como punto de corte el valor obtenido en la curva ROC (3,2mg/dL) para la máxima sensibilidad y especificidad de esta variable con relación a la mortalidad. Los pacientes cuya PCR al ingreso fue >3,2mg/dL tuvieron una mortalidad significativamente mayor que aquellos cuya cifra era <3,2mg/dL (71 frente a 10%) (p=0,002). En el análisis multivariante, las variablespronósticas de mortalidad fueron: valor preoperatorio de PCR, duración del pinzamiento aórtico e inestabilidad hemodinámica durante la intervención. Conclusiones. La elevación de la PCR preoperatoria es un factor pronóstico de mortalidad en los AAA rotos, por lo que puede ser, junto a otros factores previamente identificados, útil para la estratificación del riesgo quirúrgico de estos pacientes. [ANGIOLOGÍA 2005; 57: 225-36]

Palabras clave:
Aneurisma aórtico
Aterosclerosis
Inflamación
Proteína C reactiva
Proteínas de fase aguda
Ruptura
Summary

Aim. To determine whether the preoperative plasma values of several biological markers of inflammation –C-reactive protein (CRP), leukocytes and fibrinogen– are linked with the mortality of patients with a ruptured abdominal aortic aneurysm (AAA). Patients and methods. We performed a prospective study of 37 patients who had undergone surgery to treat a ruptured AAA. A peripheral blood sample was taken from each of the patients for use in the preoperative study of biomarkers of inflammation. Additionally, data concerning pre, intra and postoperative clinical variables were also collected. A conventional (Tina-Quant) test was used to analyse the CRP values in plasma. Results. Of the biological markers of inflammation studied, only CRP was a prognostic factor for perioperative mortality, and the mean was significantly higher in those who died than in survivors (p = 0.021). CRP was categorised in two groups using a cut-off point taken as the value obtained from the ROC curve (3.2mg/dL) for the maximum sensitivity and specificity of this variable in relation to mortality. Mortality among patients with a CRP on admission ≥ 3.2mg/dL was significantly higher than among those with a figure < 3.2mg/dL (71 versus 10%) (p = 0.002). In the multivariate analysis, the prognostic variables for mortality were: preoperative CRP value, duration of aortic clamping and haemodynamic instability during the intervention. Conclusions. Elevation of preoperative CRP levels is a prognostic factor for mortality in ruptured AAA, which means that, together with other previously identified factors, it may be useful for the stratification of surgical risk in these patients. [ANGIOLOGÍA 2005; 57: 225-36]

Palabras clave:
Acute phase proteins
Aortic aneurysm
Atherosclerosis
C-reactive protein
Inflammation
Ruptured
El Texto completo está disponible en PDF
Bibliografía
[1.]
J. Heinrich, H. Schulte, R. Schoenfeld, E. Koehler, G. Assmann.
Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain.
Thromb Haemostasis, 73 (1995), pp. 379
[2.]
E.R. Ferreiros, C.P. Boissonnet, R. Pizarro, P.F. Merletti, G. Corrado, A. Cagide, et al.
Independent prognostic value of elevated C-reactive protein in unstable angina.
Circulation, 100 (1999), pp. 1958-1963
[3.]
H. Domanovits, M. Schillinger, M. Müllner, T. Hölzenbein, K. Janata, K. Bayegan, et al.
Acute phase reactants in patients with abdominal aortic aneurysm.
Atherosclerosis, 163 (2002), pp. 297-302
[4.]
J.M. Argimón, J. Jiménez.
Métodos de investigación clínica y epidemiológica, 2, Harcourt, (1999),
[5.]
M.J. Bown, A.J. Sutton, P.R. Bell, R.D. Sayers.
A meta-analysis of 50 years of ruptured abdominal aortic aneurysm repair.
Br J Surg., 89 (2002), pp. 714-730
[6.]
J.A. Heller, A. Weinberg, R. Arons, K.V. Krishnasastry, R.T. Lyon, J.S. Deitch, et al.
Two decades of abdominal aortic aneurysm repair: have we made any progress?.
J Vasc Surg., 32 (2000), pp. 1091-1100
[7.]
M. Heikkinen, J.P. Salenius, O. Auvinen.
Ruptured abdominal aortic aneurysm in a well-defined geographic area.
J Vasc Surg., 36 (2002), pp. 291-296
[8.]
H.W. Kniemeyer, P.U. Reber, T. Kessler, H. Beckmann, H. Hakki.
Risk assessment in patients with ruptured abdominal aortic aneurysms.
Acta Chir Belg, 102 (2002), pp. 176-182
[9.]
M.M. Farooq, J.A. Freischlag, G.R. Seabrook, M.R. Moon, C. Aprahamian, J.B. Towne.
Effect of the duration of symptoms, transport time, and length of emergency room stay on morbidity and mortality in patients with ruptured abdominal aortic aneurysms.
Surgery, 119 (1996), pp. 9-14
[10.]
C.B. Ernst.
Abdominal aortic aneurysms.
N Engl J Med., 328 (1993), pp. 1167-1171
[11.]
J.C. Chen, H.D. Hildebrand, A.J. Salvian, D.C. Taylor, S. Strandberg, T.M. Myckatyn, et al.
Predictors of death in nonruptured and ruptured abdominal aortic aneurysms.
J Vasc Surg., 24 (1996), pp. 614-620
[12.]
A.A. Noel, P. Gloviczki, K.J. Cherry Jr, T.C. Bower, J.M. Panneton, G.I. Mozes, et al.
Ruptured abdominal aortic aneurysms: the excessive mortality rate of conventional repair.
J Vasc Surg., 34 (2001), pp. 41-46
[13.]
H.P. Van Dongen, J.A. Leusink, F.L. Moll, F.M. Brons, A. de Boer.
Ruptured abdominal aortic aneurysms: factors influencing postoperative mortality and long-term survival.
Eur J Vasc Endovasc Surg., 15 (1998), pp. 62-66
[14.]
F. Koskas, E. Kieffer.
Surgery for ruptured abdominal aortic aneurysm: early and late results of a prospective study by the AURC in 1989.
Ann Vasc Surg., 11 (1997), pp. 90-99
[15.]
N. Hatori, H. Yoshizu, M. Shimiu, K. Hinokiyama, S. Takeshima, T. Kimura, et al.
Prognostic factors in the surgical treatment of ruptured abdominal aortic aneurysms.
Surg Today, 30 (2000), pp. 785-790
[16.]
J.L. Cronenwett, W.C. Krupski.
Abdominal aortic aneurysm. Overview.
Vascular surgery. 5 ed, pp. 1241-1246
[17.]
C. Gabay, I. Kushner.
Acute-phase proteins and other systemic responses to inflammation.
N Engl J Med., 340 (1999), pp. 448-454
[18.]
S.M. Saadeddin, M.A. Habbab, G.A. Ferns.
Markers of inflammation and coronary artery disease.
Med Sci Monit, 8 (2002), pp. 5-12
[19.]
A.R. Folsom, J.S. Pankow, R.P. Tracy, D.K. Arnet, J.M. Peacock, Y. Hong, et al.
Association of C-reactive protein with markers of prevalent atherosclerotic disease.
Am J Cardiol., 88 (2001), pp. 112
[20.]
V. Pasceri, J. Chang, J.T. Willerson, E.T. Yeh.
Modulation of Creactive protein-mediated monocyte chemoattractan protein-1 induction in human endothelial cells by anti-atherosclerosis drugs.
Circulation, 103 (2001), pp. 2531-2534
[21.]
S. Verma, S.H. Li, M.V. Badiwala, R.D. Weisel, P.W. Fedak, R.K. Li, et al.
Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein.
Circulation, 105 (2002), pp. 1890-1896
[22.]
W.K. Lagrand, H.W. Niessen, G.J. Wolbink, L.H. Jaspars, C.A. Visser, F.W. Verheugt, et al.
C-reactive protein colocalizes with complement in human hearts during acute myocardia infarction.
Circulation, 95 (1997), pp. 97-103
[23.]
T. Vainas, T. Lubbers, F.R.M. Stassen, S.B. Herngreen, M.P. Van Dieijen-Visser, C.A. Bruggeman, et al.
Serum C-reactive protein level is associated with aortic aneurysm size and may be produced by aneurysmal tissue.
Circulation, 107 (2003), pp. 1103-1105
[24.]
K. Yasojima, C. Schwab, E.G. McGeer, P.L. McGeer.
Generation of C-reactive protein and complement components in atherosclerotic plaques.
Am J Pathol., 158 (2001), pp. 1039-1051
[25.]
M.B. Pepys, G.M. Hirschfield.
C-reactive protein: a critical update.
J Clin Invest., 111 (2003), pp. 1805-1812
Copyright © 2005. SEACV
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos